Competition

French antitrust watchdog launches public consultation regarding distribution of OTC medicines

Eveline Van Keymeulen

On 18 October 2018, the French Competition Authority (FCA) announced the opening of a public consultation relating to its sector inquiry into the distribution of medicines and biomedical laboratories launched in November 2017. Interested parties (such as healthcare professionals, pharmaceutical and health product distributors, retail pharmacies, etc.) are invited to submit comments to a set Read More

Dutch antitrust watchdog to conduct extensive investigation into proposed merger of independent treatment centres

Iradj Nazaryar

On 17 August 2018, the Dutch Authority for Consumers and Markets (ACM) published its decision that two independent treatment centres for certain specialist medical care, NL Healthcare Clinics and Bergman Clinics, must apply for a merger licence. A merger licence must be applied for where a proposed merger is not cleared by the ACM after an Read More

Commission closes infringement proceedings against Poland, Romania and Slovakia relating to parallel trade of medicines

Juraj Gyarfas

On 17 May 2018, the European Commission announced that it had decided to close its infringement procedures and the treatment of complaints related to parallel trade of medicines for human use against Poland, Romania and Slovakia. By way of background, parallel trade has long been a major concern for both governments and pharmaceutical companies in Read More

Suppliers of luxury goods can restrict online sales on (discernible) third-party platforms, says the Court of Justice

Florence Ninane

The European Court of Justice (ECJ) handed down yesterday its much awaited ruling in Coty Germany GmbH (C-230/16). It has clarified that a supplier of luxury goods can include a clause in selective distribution agreements prohibiting authorised distributors from selling those goods through non-authorised third-party platforms in a discernible manner, in order to preserve the Read More

French Competition Authority launches sector inquiry into medicinal products and biomedical laboratories

Eveline Van Keymeulen

On 20 November 2017, the French Competition Authority (FCA) launched a sector inquiry into medicinal products and medical biology (biomedical) laboratories in France.  As previously announced, the inquiry aims to address the challenges that the sector entails for the French insurance system and public health and to assess the feasibility of more competitive conditions with Read More